CoChat

Prognostic gene expression signature associated with two molecularly distinct subtypes of colorectal cancer

Open access
Oh, Sang Cheul, Park, Yun-Yong, Park, Eun Sung, Lim, Jae Yun, Kim, Soo Mi, Kim, Sang-Bae, Kim, Jongseung, Kim, Sang Cheol, Chu, In-Sun, Smith, J Joshua, Beauchamp, R Daniel, Yeatman, Timothy J, Kopetz, Scott, Lee, Ju-Seog · 2012 · Gut
Cited by 84

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Aims: Despite continual efforts to develop prognostic and predictive models of colorectal cancer by using clinicopathological and genetic parameters, a clinical test that can discriminate between patients with good or poor outcome after treatment has not been established. Thus, the authors aim to uncover subtypes of colorectal cancer that have distinct biological characteristics associated with prognosis and identify potential biomarkers that best reflect the biological and clinical characteristics of subtypes. Methods: Unsupervised hierarchical clustering analysis was applied to gene expression data from 177 patients with colorectal cancer to determine a prognostic gene expression signature. Validation of the signature was sought in two independent patient groups. The association between the signature and prognosis of patients was assessed by Kaplan–Meier plots, log-rank tests and the Cox model. Results: The authors identified a gene signature that was associated with overall survival and disease-free survival in 177 patients and validated in two independent cohorts of 213 patients. In multivariate analysis, the signature was an independent risk factor (HR 3.08; 95% CI 1.33 to 7.14; p=0.008 for overall survival). Subset analysis of patients with AJCC (American Joint Committee on Cancer) stage III cancer revealed that the signature can also identify the patients who have better outcome with adjuvant chemotherapy (CTX). Adjuvant chemotherapy significantly affected disease-free survival in patients in subtype B (3-year rate, 71.2% (CTX) vs 41.9% (no CTX); p=0.004). However, such benefit of adjuvant chemotherapy was not significant for patients in subtype A. Conclusion: The gene signature is an independent predictor of response to chemotherapy and clinical outcome in patients with colorectal cancer.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/gutjnl-2011-300812

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 84

Metadata

Authors
Oh, S. C., Park, Y.-Y., Park, E. S., Lim, J. Y., Kim, S. M., Kim, S.-B., Kim, J., Kim, S. C., Chu, I.-S., Smith, J. J., Beauchamp, R. D., Yeatman, T. J., Kopetz, S., & Lee, J.-S.
Venue
Gut
Publisher
BMJ
Published
2011-10-13
Volume
61
Issue
9
Pages
1291-1298
ISSN
  • 0017-5749 (ISSN-L)
  • 1468-3288
OpenAlex
W2113088269
Cited by
84
References
5
FWCI
3.03
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Prognostic gene expression signature associated with two molecularly distinct subtypes of colorectal cancer. https://app.cochat.ai/papers/10.1136/gutjnl-2011-300812
The paper
Oh, S. C., Park, Y.-Y., Park, E. S., Lim, J. Y., Kim, S. M., Kim, S.-B., Kim, J., Kim, S. C., Chu, I.-S., Smith, J. J., Beauchamp, R. D., Yeatman, T. J., Kopetz, S., & Lee, J.-S. (2012). Prognostic gene expression signature associated with two molecularly distinct subtypes of colorectal cancer. Gut. https://doi.org/10.1136/gutjnl-2011-300812

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.